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A B S T R A C T
Immunostaining for calbindin (CB) is commonly used to label particular populations of neurons. Recently, it has
been shown that the CA1 pyramidal cells in the mouse can be subdivided along the radial axis into superficial
and deep pyramidal cells and that this segregation in the radial axis may represent a general principle of
structural and functional organization of the hippocampus. One of the most widely used markers of the su-
perficial pyramidal cells is CB. However, this laminar segregation of pyramidal cells has not been reported in the
human CA1 using CB immunostaining. The problem is that the different pattern of CB immunostaining observed
in the mouse compared to the human could be explained by technical features, of which one of the most im-
portant is the postmortem time (PT) delay typical of the brain tissue obtained from humans. In the present study,
we have studied the influences of PT delays and fixation procedures and we found that the clear differences
found between the CA1 of the human and mouse do not depend on the fixation, but represent actual species-
specific differences. These remarkable differences between species should be taken into consideration when
making interpretations in translational studies from mouse to human brains.
1. Introduction
Many neurons of the vertebrate central nervous system express the
calcium binding protein calbindin D-28k (CB). CB immunostaining has
been used as a marker for different brain regions and to distinguish
separate populations of neurons, including pyramidal and non-pyr-
amidal cells (e.g., Celio, 1990; DeFelipe, 1997). Recently, it has been
shown that —rather than being a homogenous population of cells—
CA1 pyramidal cells in the mouse can be subdivided along the radial
axis into superficial and deep pyramidal cells, which differ in terms of a
number of characteristics regarding genetics, morphology, con-
nectivity, and electrophysiology (Danielson et al., 2016; Fattahi et al.,
2018; Geiller et al., 2017; Soltesz and Losonczy, 2018). It has been
proposed that this segregation based on the radial axis may represent a
general principle of organization in the hippocampus that increases the
capacity of the hippocampus to compute and process several tasks in
parallel (Fattahi et al., 2018; Geiller et al., 2017). One of the most
commonly used markers of the superficial pyramidal cells in the mouse
is CB. However, the laminar segregation of pyramidal cells described
above has not been reported in the human CA1 using immunostaining
for CB (Ding and Van Hoesen, 2015; Seress et al., 1992, 1993; Sloviter
et al., 1991; Arellano et al., 2004). Nevertheless, the description of the
pattern of immunostaining in the human CA1 differs between different
laboratories. For example, Sloviter et al. (1991) and Ding and Van
Hoesen (2015) did not observe CB-immunoreactive (-ir) pyramidal cells
in CA1 (most were non-pyramidal cells), whereas Seress et al. (1992,
1993), Wittner et al. (2002), Abrahám et al. (2009), and Maglóczky
(2010) reported relatively high numbers of labeled pyramidal cells. The
divergent observations from human hippocampal CA1 and the different
pattern of CB immunostaining observed in the mouse compared to the
human could be explained by technical features. For example, using
different fixatives or differences in the fixation procedure —brain tissue
obtained after perfusion versus immersion-fixed brain tissue extracted
immediately after death (postmortem time [PT] 0 h, 0min) or after
several PT delays— have been shown to alter a number of metabolic
and immunostaining characteristics of the brain tissue (e.g., Gonzalez-
Riano et al., 2017; Lavenex et al., 2009). However, it is common to
describe similar or different patterns of immunostaining when com-
paring brain tissue from humans with experimental animals without
considering these critical methodological factors. Therefore, it is not
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clear to what extent technical factors account for the different ob-
servations between human and mouse CA1 —as well as the differences
found by different laboratories— and to what extent such differences
can be attributed to actual species-specific differences.
In the present study, we have further examined possible influences
of PT delays, fixation procedures, and different fixative solutions on the
patterns of CB immunostaining in both human and mouse CA1.
2. Material and methods
2.1. Human brain tissue
Two types of human hippocampal samples were used in the present
study: autopsy samples—from 4 control cases (PT between 2 and 4 h)—
and biopsy samples from postoperative tissue samples from an epileptic
patient suffering from pharmacoresistant temporal lobe epilepsy (TLE)
with a hippocampus without histopathological alterations (Table 1).
This tissue has been used in previous studies where detailed informa-
tion about the cases can be found (Arellano et al., 2004; Arion et al.,
2006; Kastanauskaite et al., 2009; Inda et al., 2007; Muñoz et al., 2007;
Tapia-González et al., 2019). The tissue was obtained following na-
tional laws and international ethical and technical guidelines on the use
of human samples for biomedical research purposes.
Upon removal, the human brains were immediately fixed in cold 4%
paraformaldehyde (PFA) in phosphate buffer (0.1M, pH 7.4) and small
blocks of the hippocampal formation and adjacent cortex were then
obtained and post-fixed in the same fixative solution for 24 h at 4 °C.
After fixation, vibratome sections of the cortical tissue (50 μm) were
obtained and processed for histology or immunostaining.
2.2. Mouse brain tissue
In order to perform comparative studies between humans and mice
in the present study, we examined CB-ir in two groups of mice as de-
scribed in our previous study (Gonzalez-Riano et al., 2017). Two-
month-old male C57BL/6 J mice (Charles River Laboratories, Wil-
mington, MA) were used in both groups. Animals were kept in a 12:12-
h light/dark cycle and received food and water ad libitum. All experi-
mental protocols involving the use of animals were performed in ac-
cordance with recommendations for the proper care and use of la-
boratory animals, and under the authorization of the regulations and
policies governing the care and use of laboratory animals [EU directive
no. 86/609 and Council of Europe Convention ETS1 23, EU decree
2001-486 and Statement of Compliance with Standards for Use of La-
boratory Animals by Foreign Institutions no. A5388-01, National In-
stitutes of Health (USA)]. Special care was taken to minimize animal
suffering and to reduce the number of animals used to the minimum
required for this study.
The animals from the first group (n= 3) were anaesthetized with a
lethal pentobarbital injection (40mg/kg BW, Vetoquinol, Madrid,
Spain) and transcardially perfused with a saline solution followed by
4% PFA in PB. The brains were removed, post-fixed by immersion in the
same fixative for 20 h at 4 °C and cryoprotected in 30% sucrose. To test
the possible effects of PT on CB immunostaining, we used a second
group of mice that were sacrificed with the same pentobarbital lethal
injection as described above. Thereafter, their brains were removed at
0, 2 and 5 h PT, respectively (n= 3 mice, per interval), fixed in 4% PFA
in PB overnight (20 h) at 4 °C. Thereafter, the brains from the two
groups of animals were cut into 50-μm-thick coronal slices with a
freezing sliding microtome (Microm HM 450, Microm International,
Germany) and processed for immunocytochemistry (immunoperoxidase
and immunofluorescence).
2.3. Immunohistochemistry
Single immunohistochemistry was performed in free-floating
human and mouse sections. The sections were first pre-treated with 2%
H2O2 for 30min to remove the endogenous peroxidase activity and the
slices were then blocked for 1 h in PB (0.1 M) with 0.25% Triton X-100
and 3% normal goat serum (Vector Laboratories Inc., Burlingame, CA,
USA). Then, the sections were incubated overnight at 4 °C with the
primary antibody rabbit anti-calbindin D28 K (CB-38a; Swant,
Switzerland; 1:2000). On the following day, the sections were rinsed in
PB and incubated for 2 h with biotinylated goat anti-rabbit IgG anti-
body (BA2000, Vector laboratories, Burlingame, CA; 1:250). After
several washes in PB, the sections were incubated for 1 h at room
temperature with avidin–biotin peroxidase complex (Vectastain ABC
Elite PK6100, Vector; diluted 1:125). The staining was then performed
with 0.01% hydrogen peroxide with 3, 3´ diaminobenzidine tetra-
hydrochloride chromogen (DAB: Sigma-Aldrich, St. Louis, MO, USA).
All sections were incubated until they turned light brown, with the
same duration of incubation for all slides; the immunostaining was
checked via light microscope before stopping the reaction in all slides.
Then, the sections were incubated in 0.02% OsO4 in PB for 15 s at room
temperature. Finally, the sections were mounted, dehydrated and
cleared with xylene and coverslipped with DPX (Fluka AG, Buchs,
Switzerland). Sections from every patient were Nissl-stained in order to
identify the cortical areas and the laminar boundaries.
For immunofluorescence, free-floating sections were blocked for 1 h
in PB with 0.25% Triton X-100 and 3% normal goat serum and in-
cubated overnight at 4 °C with the antibody rabbit anti-calbindin D28 K
(CB-38a; Swant, Switzerland; 1:2000). The sections were then rinsed in
PB and incubated for 2 h at room temperature with Alexa Fluor 594-
conjugated goat anti-rabbit antibody (A11012, Molecular Probes,
Madrid, Spain; 1:1000). The nuclei from every mouse section were
counterstained with DAPI (4, 6-diamidino-2-phenylindole) (Sigma, San
Louis; MO; 1:80). To eliminate lipofuscin autofluorescence in human
samples, eliminator reagent (2160, Millipore) was used following the
manufacturer’s instructions. Finally, sections were mounted and cov-
erslipped with ProLong ® Gold antifade reagent (Life technologies,
Carlsbad, CA). To confirm the specificity of CB-38a for DAB and
fluorescence immunostaining, negative controls were performed in
parallel with the primary experiments, omitting the primary antibody
under the same conditions.
To test the possible effects of different fixative solutions on CB im-
munostaining, prior to the above-mentioned immunostaining proce-
dure, we exposed human and mouse brain sections already fixed with
PFA to a mixture of 4% PFA and glutaraldehyde (0.125%) in PB for 1 h.
Table 1
Summary of technical information of the human cases. The human case codes are internal codes to ensure the confidentiality of each human sample.
Human case code Age (y) Sex Postmortem delay (h:min) Source Fixation procedure
M8 69 Male 2:30 Autopsy Immersion-fixed
M7 49 Male 2 Autopsy Immersion-fixed
AB3 53 Male 3:20 Autopsy Immersion-fixed
AB2 50 Female 4 Autopsy Immersion-fixed
H65 21 Female – Biopsy* Immersion-fixed
*Non sclerotic hippocampus obtained from postoperative tissue samples (biopsy) from an epileptic patient suffering from pharmacoresistant temporal lobe epilepsy.
See Materials and Methods for further information.
P. Merino-Serrais, et al. Journal of Chemical Neuroanatomy 104 (2020) 101745
2
3. Results
We performed immunostaining techniques which aimed to analyze
possible effects of PT delay, fixation procedures and different fixative
solutions on the pattern of CB-immunostaining in CA1 pyramidal cell
layer from human and mouse brains. As previously discussed in
Gonzalez-Riano et al. (2017), since small changes are typically found
from experiment to experiment, subtle changes are difficult to interpret.
Thus, we were only looking for large, obvious changes. Therefore, we
qualitatively analyzed the staining pattern for CB in CA1 pyramidal cell
layer of (i) the human hippocampal body according to the indications of
the atlas of Mai et al. (2016) and (ii) the dorsal mouse hippocampus
from Bregma −1.46 to −2.30 (Paxinos and Franklin, 2001).
3.1. CA1 pyramidal cell layer has a different distribution of CB-ir neurons
in human compared with mouse
As shown in Fig. 1, CB-ir neurons in the human CA1 were dis-
tributed in the CA1 pyramidal cell layer without any apparent pre-
ference in the radial aspect. The vast majority of well-labeled neurons
were identified as non-pyramidal cells by morphological criteria. In
addition, some CB-ir neurons were identified as pyramidal neurons but
they were rather scarce (Figs. 1B, 2 B, C, and 3 C, D). However, rela-
tively numerous CB-ir pyramidal neurons were found in CA2 (Fig. 1C)
in the same preparations. In the mouse CA1, CB-ir neurons were located
mainly in the CA1 superficial layer (Fig. 4) forming a well stratified
“CB-ir pyramidal cell layer”. The relative proportions of the two types
of CB-ir neuron were observed to be the opposite to that seen in hu-
mans: most CB-ir neurons were identified as pyramidal cells, whereas
relatively few were identified as non-pyramidal neurons.
3.2. The pattern of CB distribution is not affected by different short PT
delays or different fixative procedures
No changes in the general pattern of distribution of CB im-
munostaining throughout the CA1 pyramidal cell layer were observed
in either human or mouse brains with PT up to 5 h (Figs. 1–4). How-
ever, we observed a slightly higher intensity in the immunostaining of
the CA1 neuropil of the mouse brain fixed by immersion that was ex-
tracted immediately after death (PT, 0 h 0min) (Fig. 4E and I) com-
pared to perfused-fixed brain (Fig. 4D and H). Furthermore, we ob-
served a lower immunostaining intensity in cell bodies, neuronal
Fig. 1. CB-ir neurons show no sub-laminar distribution in human CA1 pyramidal cell layer. (A) Low-power photomicrograph of a section immunostained for
CB from the hippocampal formation obtained from autopsy. (B) Higher magnification of the area indicated by a rectangle in A to show the pattern of immunostaining
in CA1. (C) Representative image of CA2 taken from A. Arrows in C indicate some pyramidal neurons which are relatively numerous compared to CA1 (B). Or,
stratum oriens; Pyr, stratum pyramidale; Rad, stratum radiatum; Alv, alveus; Scale bar shown in A indicates 1000 μm in A, 170 μm in B, and 120 μm in C.
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processes and neuropil in immersion-fixed mouse tissue extracted after
2 h up to 5 h PT (Fig. 4F and J), as compared to tissue from perfused
animals (Fig. 4D and H) or immersion-fixed mouse brain 0 h 0min PT
(Fig. 4E and I). Finally, we tested the possible effects on CB
immunostaining in brain tissue fixed with a mixture of glutaraldehyde
and paraformaldehyde. We found that the pattern of immunostaining
did not change in either humans or mice (Figs. 3 and 4). Nevertheless,
the inclusion of glutaraldehyde in the fixative produced a general
Fig. 2. Visualization of fluorescence-immunostained CB-ir neurons in sections from the human hippocampus. (A) CB fluorescence immunostained image
showing a panoramic view of the hippocampus obtained from autopsy. Note that there is not a sub-laminar distribution of labeled neurons in the CA1 pyramidal cell
layer. (B, C) Images taken from A at a higher magnification. The immunostaining is similar to that found in sections stained for DAB (see Fig. 1 B). Lac-mol, stratum
lacunosum-moleculare; Or, stratum oriens; Pyr, stratum pyramidale; Rad, stratum radiatum; Alv, alveus. Scale bar shown in C indicates 800 μm in A, 50 μm in B and
50 μm in C.
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reduction in the background of the immunostaining in both human and
mouse samples (Figs. 3E, F and 4 E, G).
4. Discussion and conclusion
In the present study, we further emphasize that there are clear
differences in the pattern of immunostaining for CB in the CA1 of the
human compared to the mouse, and that these differences do not de-
pend on the fixation of the brain tissue but rather reflect actual species-
specific differences.
The most remarkable differences are the following: most studies
report that in the human, relatively few labeled neurons are present in
CA1, where they are distributed without an obvious laminar preference,
e.g., Sloviter et al. (1991); Ding and Van Hoesen (2015) and our own
studies (although it should be noted that not all studies reached this
conclusion; see Seress et al. (1992, 1993), Wittner et al. (2002),
Abrahám et al., (2009), and Maglóczky (2010). Furthermore, both
pyramidal and non-pyramidal neurons are labeled but the majority of
well-labeled neurons can be identified as non-pyramidal cells. In the
mouse, again both pyramidal cells and non-pyramidal cells are labeled
but the labeled pyramidal cells are so numerous in the superficial aspect
of the CA1 pyramidal cell layer that the labeled cells form a continuous
row such that the superficial pyramidal cell layer of CA1 is clearly
delimitated.
It is important to point out that the relatively few CB-ir cells present
in the human CA1 observed in the present study is in line with the
human transcriptome map obtained using in situ hybridization by
Hawrylycz et al. (2012), showing that CB is strongly expressed in CA1
of the mouse but not in the human CA1. Furthermore, we found that
CB-ir pyramidal cells are very numerous in the human CA2, which is
Fig. 3. Photomicrographs of sections immunostained for CB in the human CA1 pyramidal cell layer from case H65 (A) and case AB3 (C and E). B, D and F are higher
magnifications of A, C and E, respectively. Arrows in C and D indicate a labeled pyramidal neuron. Sections shown in A and D were from brain tissue fixed in PFA,
whereas the section shown in E, F was fixed with a mixture of PFA and glutaraldehyde. Scale bar shown in F indicates 70 μm in A, C, E, and 50 μm in B, D, F.
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also consistent with the robust expression of CB observed using in situ
hybridization. The present results further highlight species differences
of the hippocampus with regard to a number of anatomical, neuro-
chemical, genetic and physiological characteristics (e.g., Hof et al.,
1996; Hawrylycz et al., 2012; Mashiko et al., 2012; Slomianka et al.,
2013; Ding, 2013; van Dijk et al., 2016; Tapia-González et al., 2019;
Benavides-Piccione et al., 2019). However, most studies emphasize the
similarities between species, with the differences often not being con-
sidered when extrapolating data from the hippocampus from one spe-
cies to another. For example, the obvious differences in the cytoarchi-
tecture of CA1 between the human and mouse is often not taken into
consideration when dealing with the functional and connectivity
Fig. 4. CB-ir neurons show sub-laminar distribution in mouse CA1 pyramidal cell layer. CB immunostaining in mouse hippocampus under different experi-
mental conditions. (A–C) Low-magnification photomicrographs showing CB immunostaining of sections from the hippocampus of a perfused brain (A), or fixed by
immersion immediately after death (PT 0 h, 0min) (B), or by immersion after 5 h PT (C). (D–G) High-magnification photomicrographs to show in greater detail the
differences in immunostaining under different experimental conditions. The areas indicated by a rectangle in A, B and C are shown at a higher magnification in D, F
and E, respectively. (H–J) Confocal images taken from the pyramidal cell layer of CA1 in sections immunostained for CB and counterstained with DAPI from a
perfused mouse brain (H), or fixed by immersion immediately after death (PT 0 h, 0min) (I), or by immersion after 5 h PT (J). Scale bar shown in J indicates 250 μm
in A–C, 43 μm in D–G and 48 μm in H–J.
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interpretation of data obtained in mice and humans. As recently dis-
cussed in Benavides-Piccione et al. (2019), the consequences of the fact
that the human pyramidal cell layer of CA1 is much less densely packed
than that of the mouse is frequently ignored. This is sometimes referred
to as “corticalization” of the human CA1 pyramidal cell layer because it
resembles a neocortical cytoarchitecture. From the point of view of
connectivity, this corticalization has an important impact on the local
circuits since the basal and apical dendrites of human pyramidal cells
are intermixed in the pyramidal cell layer, whereas —in the mouse—
the basal and apical dendritic domains are basically separated (basal
dendrites in the stratum oriens; apical dendrites in the stratum ra-
diatum). In addition, to the differences in the expression of CB in the
human and mouse pyramidal cells, human CA1 pyramidal cells are
larger and have a different structural organization compared to mouse
CA1 pyramidal cells regarding particular morphological features, which
must reflect differences in cortical processing of information
(Benavides-Piccione et al., 2019). In conclusion, the remarkable dif-
ferences between species should be taken into consideration in order to
make appropriate interpretations in translational studies from mouse to
human brains.
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